PE
BHVN icon

Point72 Europe’s Biohaven BHVN Stock Holding History

Point72 Europe’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$80.9K Buy
+5,393
New +$78.5K ﹤0.01% 300

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Europe's BHVN Position: Q3 2025 in Review

Point72 Europe opened a new position in Biohaven (BHVN) in Q3 2025: 5,393 shares worth $80.9K. The stake represents ﹤0.01% of the portfolio and ranks #300 among its holdings.

264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • Point72 Europe held 5,393 shares of Biohaven worth $80.9K as of Q3 2025.
  • Biohaven was a new Point72 Europe position in Q3 2025.
  • Biohaven made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #300 holding.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.